{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:52:31Z","timestamp":1790837551904,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T00:00:00Z","timestamp":1232928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T00:00:00Z","timestamp":1232928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/bmt.2009.7","type":"journal-article","created":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T12:42:26Z","timestamp":1232973746000},"page":"275-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies"],"prefix":"10.1038","volume":"43","author":[{"given":"A","family":"Gratwohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Baldomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schwendener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Apperley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Frauendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Joint Accreditation Committee of the International Society for Cellular Therapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,26]]},"reference":[{"key":"BFbmt20097_CR1","first-page":"197","volume":"8","author":"A Gratwohl","year":"1991","unstructured":"Gratwohl A . Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197\u2013201.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20097_CR2","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1182\/blood-2002-03-0675","volume":"100","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A . Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374\u20132386.","journal-title":"Blood"},{"key":"BFbmt20097_CR3","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3324\/haematol.11260","volume":"92","author":"A Gratwohl","year":"2007","unstructured":"Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Niederwieser D, et al., Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; European Leukemia Net. Predictability of hematopoietic stem cell transplantation rates. Haematologica 2007; 92: 1679\u20131686.","journal-title":"Haematologica"},{"key":"BFbmt20097_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.bmt.1705956","volume":"41","author":"A Gratwohl","year":"2008","unstructured":"Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D, Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT); European Group for Blood and Marrow Transplantation EBMT (JACIE). The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant 2008; 41: 687\u2013705.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20097_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bmt.1705104","volume":"36","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A . Change in stem cell source for hematopoietic stem cell transplantation in Europe. Bone Marrow Transplantation 2005; 36: 575\u2013590.","journal-title":"Bone Marrow Transplantation"},{"key":"BFbmt20097_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/sj.bmt.1705555","volume":"39","author":"A Gratwohl","year":"2007","unstructured":"Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D, Joint Accreditation Committee of the International Society for Cellular Therapy ISCT; European Group for Blood and Marrow Transplantation EBMT. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007; 39: 71\u201387.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20097_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jcp.20959","volume":"211","author":"A Giordano","year":"2007","unstructured":"Giordano A, Galderisi U, Marino IR . From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211: 27\u201335.","journal-title":"J Cell Physiol"},{"key":"BFbmt20097_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jamcollsurg.2008.04.013","volume":"207","author":"NM Novotny","year":"2008","unstructured":"Novotny NM, Ray R, Markel TA, Crisostomo PR, Wang M, Wang Y et al. Stem cell therapy in myocardial repair and remodeling. J Am Coll Surg 2008; 207: 423\u2013434.","journal-title":"J Am Coll Surg"},{"key":"BFbmt20097_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/hrt.2008.149476","volume":"94","author":"SL Beeres","year":"2008","unstructured":"Beeres SL, Atsma DE, van Ramshorst J, Schalij MJ, Bax JJ . Cell therapy for ischaemic heart disease. Heart 2008; 94: 1214\u20131226.","journal-title":"Heart"},{"key":"BFbmt20097_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/archneur.65.4.452","volume":"65","author":"O Einstein","year":"2008","unstructured":"Einstein O, Ben-Hur T . The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol 2008; 65: 452\u2013456.","journal-title":"Arch Neurol"},{"key":"BFbmt20097_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.bmt.1705265","volume":"37","author":"P Ljungman","year":"2006","unstructured":"Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H et al., European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006; 37: 439\u2013449.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20097_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2141.2002.03440.x","volume":"117","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A, for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilisation of haematopoietic stem cell transplants in Europe. Br J Haematol 2002; 117: 451\u2013468.","journal-title":"Br J Haematol"},{"key":"BFbmt20097_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.cco.0000208781.61452.d3","volume":"18","author":"AW Loren","year":"2006","unstructured":"Loren AW, Porter DL . Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation. Curr Opin Oncol 2006; 18: 107\u2013114.","journal-title":"Curr Opin Oncol"},{"key":"BFbmt20097_CR14","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","volume":"25","author":"C Schmid","year":"2007","unstructured":"Schmid C, Labopin M, Nagler A, Bornh\u00e4user M, Finke J, Fassas A et al., EBMT Acute Leukemia Working Party. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 2007; 25: 4938\u20134945.","journal-title":"J Clin Oncol"},{"key":"BFbmt20097_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.V100.2.397","volume":"100","author":"C Guglielmi","year":"2002","unstructured":"Guglielmi C, Arcese W, Dazzi F, Brand R, Bunjes D, Verdonck LF et al. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood 2002; 100: 397\u2013405.","journal-title":"Blood"},{"key":"BFbmt20097_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/CCO.0b013e3282f0e116","volume":"19","author":"F Dazzi","year":"2007","unstructured":"Dazzi F, Horwood NJ . Potential of mesenchymal stem cell therapy. Curr Opin Oncol 2007; 19: 650\u2013655.","journal-title":"Curr Opin Oncol"},{"key":"BFbmt20097_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"E Horwitz","year":"2005","unstructured":"Horwitz E, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini F et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393\u2013395.","journal-title":"Cytotherapy"},{"key":"BFbmt20097_CR18","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579\u20131586.","journal-title":"Lancet"},{"key":"BFbmt20097_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/art.22111","volume":"55","author":"A Tyndall","year":"2006","unstructured":"Tyndall A, LeBlanc K . Stem cells and rheumatology: update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum 2006; 55: 521\u2013525.","journal-title":"Arthritis Rheum"},{"key":"BFbmt20097_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbmt.2008.02.019","volume":"14","author":"M Hamadani","year":"2008","unstructured":"Hamadani M, Awan FT, Copelan EA . Hematopoietic stem cell transplantation in adults with acute myeloid leukemia. Biol Blood Marrow Transplant 2008; 14: 556\u2013567.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20097_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.beha.2007.11.013","volume":"21","author":"FR Appelbaum","year":"2008","unstructured":"Appelbaum FR . Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML). Best Pract Res Clin Haematol 2008; 21: 85\u201392.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFbmt20097_CR22","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1182\/blood-2006-06-025627","volume":"109","author":"JJ Cornelissen","year":"2007","unstructured":"Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM et al. Results of a HOVON\/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood 2007; 109: 3658\u20133666.","journal-title":"Blood"},{"key":"BFbmt20097_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.beha.2007.11.005","volume":"21","author":"M Marcondes","year":"2008","unstructured":"Marcondes M, Deeg HJ . Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): when, how and for whom? Best Pract Res Clin Haematol 2008; 21: 67\u201377.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFbmt20097_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.seminhematol.2007.10.005","volume":"45","author":"AJ Barrett","year":"2008","unstructured":"Barrett AJ, Savani BN . Allogeneic stem cell transplantation for myelodysplastic syndrome. Semin Hematol 2008; 45: 49\u201359.","journal-title":"Semin Hematol"},{"key":"BFbmt20097_CR25","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1200\/JCO.2007.15.5184","volume":"26","author":"J Schetelig","year":"2008","unstructured":"Schetelig J, Bornh\u00e4user M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative german transplant study group. J Clin Oncol 2008; 26: 5183\u20135191.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt20097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20097","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:13:54Z","timestamp":1648037634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt20097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,26]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFbmt20097"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,26]]},"assertion":[{"value":"24 September 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}